Notably, when we compared amplifications and deletions of GLS2 among the PAM50 subtypes, we observed that the majority of the GLS2 copy number deletions occurred in the mesenchymal stem cell-rich basal-like breast cancer subtype (Supplementary Figure S1G). The gene discussed is GLS2; the disease is breast carcinoma.